Drooid Logo
Back to story perspectives

Full Breakdown

Raising Awareness for CTBP1 Mutation: A Mother's Journey

2/17/2026, 11:03:43 AM

Understanding Halo's Condition

Two-year-old Halo, from Albany, is diagnosed with a mutation of the CTBP1 gene, categorizing her condition as part of the "ultra rare disease" classification. Her mother, Theresa Little, has taken it upon herself to raise awareness about Halo's condition and the challenges it presents. Initially, Halo appeared to be a typical infant, but by four months, her mother noticed developmental delays, prompting consultations with various medical professionals, including a pediatrician, neurologist, and geneticist.

The Diagnostic Journey

Halo underwent extensive testing, including imaging, bloodwork, and whole exome sequencing, which ultimately confirmed the CTBP1 mutation after ten months of uncertainty. Dr. Carlos Mares Beltran, a geneticist and pediatrician at Albany Medical Center, explained that this mutation leads to "non-specific developmental delays, low muscle tone, speech problems, and walking issues." As a result, Halo relies on a feeding tube for nutrition and receives additional support through physical and occupational therapy at her daycare.

The Role of Research and Community

Due to the rarity of the CTBP1 mutation, there is limited information available regarding its long-term implications. Dr. Beltran emphasizes the importance of research in this area and actively shares resources with families affected by similar conditions. Theresa Little has connected with other families globally who are navigating the challenges associated with the CTBP1 mutation, fostering a community of support and shared knowledge.

Commitment to Research Funding

In an effort to contribute to the understanding and treatment of rare genetic disorders, a portion of the proceeds from fundraising efforts is donated to medical research focused on conditions like Halo's. This initiative not only supports scientific inquiry but also raises awareness about the challenges faced by families dealing with ultra rare diseases.

Conclusion

Theresa Little's advocacy for her daughter Halo highlights the complexities of living with a rare genetic condition. Through her efforts, she aims to provide clarity and support for other families while contributing to the broader understanding of CTBP1 mutations and their impact on children's lives.